Sorry mate, my question was not for IMU. I only asked here since there are lots of talks here. I am more thinking like in the past, how some spec companies purportedly have very good product, but got nowhere both in terms of sales and share price. Only for it to then be bought out cheaply by a predator. So in such a case, if there is share price shorting, I was just wondering what happened then.
So please don't read too much into my question for here. After all, when our drugs is proven to be the best in terms of tolerability and efficacy, it does not matter what the share price is. All it matters is an interest from a few big pharma and their bids will get it to the right price for IMU.
Re:Re:Charts:Imugene, page-964
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(0.91%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $289.8K | 5.274M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 3713179 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 345634 | 15 |
View Market Depth
| Last trade - 12.52pm 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |